USPTO Deadlines
Application History
25 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 14, 2023 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Aug 14, 2023 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jan 10, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 27, 2022 | ETOP | T | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | Loading... |
| Sep 8, 2022 | WOAR | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED | Loading... |
| Sep 8, 2022 | WOAG | I | WITHDRAWAL OF ATTORNEY GRANTED | Loading... |
| Sep 6, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Sep 6, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Sep 6, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Aug 4, 2022 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED | Loading... |
| Jul 19, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 19, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 29, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 10, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jun 10, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 10, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 10, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jun 10, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 9, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 9, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 9, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 9, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 19, 2021 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Oct 16, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 8, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer; anti-cancer preparations; Pharmaceutical products for the treatment of cancer and viral and infectious diseases
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Research and development of pharmaceuticals for the treatment of cancer; Medical and scientific research in the field of cancer treatment
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of a three dimensional triangle composed of three sides, each of the three sides being a rectangular prism. The literal element PENROSE is positioned to the right of the three dimensional triangle in block letters. Below the literal element PENROSE is the literal element TherapeuTx. The literal elements PENROSE and TherapeuTx are stacked and vertically aligned with the three dimensional triangle design to the left thereof.
Classification
International Classes
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"THERAPEUTICS"